derya-unutmaz-16f5c381·1 events·first seen Aliases: Derya Unutmaz
OpenAI published a case study describing how immunologist Derya Unutmaz used GPT-5 Pro to resolve a three-year-old mystery about T cell behavior. The breakthrough has potential implications for cancer and autoimmune disease research. This is a first-party deployment case study from OpenAI highlighting scientific discovery use cases for their flagship model.